When you compare stimulant rehab success rates, remember that no single percentage proves a program works. A number only means something if the program explains what outcome it measured. It should also say who was counted, how long they were followed, and how the data was collected.
Look for care that matches evidence-supported stimulant treatments. These include behavioral therapies and contingency management.
For a broader look at reading outcome numbers, see our guide to how to verify rehab outcomes. This article focuses on stimulant-specific claims.
We are a U.S. treatment directory publisher, not a treatment provider.
Why One Percentage Cannot Tell the Whole Story
There is no single, standardized national measure that lets you compare every stimulant rehab program on equal terms. When a facility posts a success rate, it reflects how that program defines success, who it counts, and when it measures. A number from one place cannot be lined up against another without knowing those details.
To see why context matters, look at how research is built. Earlier trials in the same network had evaluated a similar non-computerized motivational incentives intervention over 12 weeks.[1] These are details about the study design, not an expected outcome or a success rate for any facility.
What the research does show is specific to the intervention and the people studied. Across multiple studies, contingency management produced longer stretches of continuous abstinence from stimulants than cognitive behavioral therapy did during treatment.[2] That finding supports contingency management as an effective approach. It does not certify a particular clinic’s advertised percentage.
When you read evidence-based stimulant addiction care, think about whether a program uses methods with this kind of research backing, rather than chasing one headline number.
12 weeks
was the intervention period in earlier CTN trials of motivational incentives[1]
Define What Treatment Success Means
When a program shares a success rate, ask what they are measuring. Different outcomes answer different questions. A high completion rate does not prove long-term recovery, and abstinence at discharge does not guarantee stability months later.

Use this table to help you compare how programs define their results.
| Outcome Measure | What It Can Tell You | What It Cannot Establish Alone |
|---|---|---|
| Treatment Retention or Completion | How many people stayed in the program or finished the planned course of care. | Whether participants achieved lasting recovery or improved health after leaving. |
| Abstinence | Whether a person reported no use or tested negative for substances at a specific point in time. | Overall well-being, social functioning, or the likelihood of future relapse. |
| Reduced Use | Whether frequency or amount of use decreased compared to before treatment. | Full remission from stimulant use disorder or complete cessation of all substances. |
| Functioning or Quality of Life | Improvements in work, relationships, housing stability, or mental health symptoms. | Direct proof that the reduction in substance use caused these life improvements. |
A reputable program should label each number clearly. Be cautious if they combine these measures into one vague percentage without explaining the timeframe.
It also matters when the outcome was measured. Did they count people who completed the program? Or did they follow up with patients six months after discharge? Ask for specifics on timing and method. This helps you understand if the claim reflects immediate engagement or long-term support.
Choosing the right level of care is another factor that influences outcomes. You can learn more about inpatient vs outpatient stimulant treatment to see which setting fits your needs best.
Audit a Program's Outcome Claim
When a program shares a success rate, ask how they got that number. The details behind the percentage matter as much as the number itself. Use the questions below to learn what was measured and who was counted.
Questions to Ask About a Program’s Outcome Data
Your ticks are saved on this device only.
Pay close attention to whether the rate includes everyone who started treatment or only those who completed it. A high completion rate can look impressive if it leaves out people who dropped out early. Also ask how they tracked substance use. Drug testing is only one measure of one treatment goal and should not be the only method used to monitor outcomes.[3] Good programs combine test results with self-reports and other indicators.
This next self-check helps you see how clear a claim is. It does not judge clinical quality or predict your personal results.
How Interpretable Is This Claim?
This self-check is for information only and isn't a diagnosis or a rating of treatment quality.
Check What Stimulant-Specific Care the Program Provides
Once you understand a program's success rate, look at the care behind it. Ask what specific treatments they offer for stimulant use disorder, who provides them, how often sessions happen, and how they track your progress. The table below lists common approaches and the questions to ask.
| Approach | What to ask the program | How delivery can be described | What evidence or limits to clarify |
|---|---|---|---|
| Contingency management | Do you use rewards for staying in treatment or testing negative? Who runs it? | Structured incentives tied to clear goals, often weekly or more often | The ASAM/AAAP guideline recommends contingency management as a primary component of treatment for stimulant use disorder.[4] It works best alongside other supports.[2] |
| CBT or related behavioral therapies | What kind of counseling do you use? Is it structured? How often? | Individual or group sessions focused on triggers, coping skills and follow-up plans | Behavioral therapies are part of recommended care for stimulant use disorder.[2] Ask how they measure improvement. No single approach guarantees an outcome. |
| Matrix Model | Do you follow the Matrix Model? Which parts apply here? Who facilitates it? | A protocolized form of CBT with added elements, used in outpatient or residential settings[2] | The Matrix Model is included among behavioral treatments for stimulant use disorder in the ASAM/AAAP guideline.[2] Read more in our guide to Matrix Model vs CBT for stimulants. |
| Medication evaluation | Do you screen for co-occurring conditions and review medications regularly? Who prescribes them? | Regular check-ins with a prescriber to adjust plans safely | There are currently no FDA-approved medications for treating stimulant use disorders.[5] Some doctors may discuss off-label options; ask about risks and monitoring. Learn more about medication options for stimulant use disorder. |
No one size fits all. A good program explains why they chose a method and how they will adapt if it isn't working.
Set Aside Numbers From Different Systems
You may see stats that look helpful but measure something else. These numbers often come from different groups or treatments. So, they do not show how well a facility treats stimulants.

Drug court outcomes are one common example. These programs track legal supervision for people in the justice system. Referral eligibility varies by jurisdiction and program, typically serving individuals with substance use issues involved in the legal system. Success often means staying out of trouble or finishing legal steps. That is not the same as clinical recovery in a rehab center. Drug-court rates vary by program, population, outcome, and follow-up period, so there is no single rate directly comparable to rehab. A good drug court result does not prove a clinic’s stimulant care works for everyone.
You might also see high success rates for meds like Suboxone. It is important to know what this drug treats. The FDA has approved medications for opioid use disorder, but there are currently no FDA-approved medications for treating stimulant use disorders.[6] Suboxone outcome rates vary with the population, treatment duration, and outcome measured. Since the conditions and treatments differ, opioid med results do not predict stimulant care success.
Be careful with claims that one addiction has the "highest" or "lowest" relapse rate. Relapse is common in chronic health conditions. Returning to use does not mean treatment failed or that more care cannot help. Comparisons are only fair if they use the same definitions and follow people for the same time. Without those details, these rankings are misleading and should not guide your choice.
Compare Programs and Verify the Basics
Comparing programs is easier when you line them up on similar terms. Start by matching the treatment setting and the people served. A residential program for people with co-occurring conditions isn't comparable to an outpatient clinic for mild stimulant use.
Keep legitimacy checks separate from outcome claims. Licensing and accreditation tell you a program meets legal and industry standards. They don't prove it produces a particular result, such as long-term sobriety. You can learn how to verify a rehab license and accreditation in our verification guide.
- Identify the setting and population you need. Decide whether you need inpatient, outpatient, or another level of care. Look for programs that serve people with stimulant use concerns specifically.
- Ask each program the same questions. Request their outcome measures, how they define success, what follow-up they do, and what percentage of clients completed the program versus dropped out early.
- Check licensing and accreditation separately. Verify that the program has any state license required for its services. Accreditation can offer another quality check, but it is not a substitute for outcome data or a universal requirement.
- Compare answers side by side. Write down what each program told you about outcomes, follow-up rates, and dropout rates. If a number lacks context, such as no denominator or timeframe, ask for clarification before making your choice.
Once you have answers from two or three programs, you can weigh them against your priorities. Think about cost, location, insurance acceptance, family involvement options, and aftercare support.
Frequently Asked Questions
What percentage of people relapse after rehab?
There is no single number that fits everyone. Estimates vary because programs define relapse differently. They also check at different times. When you compare programs, ask how each one defines relapse. Ask when they measure it, too. Numbers based on different rules are not comparable.
How long after treatment should a program track outcomes?
Ask which follow-up points the program reports. Also ask how many people it reached at each point. Tracking over time shows if gains hold up. A result from one point should not stand in for a later one. Look for clear reporting on who answered and when.
Does a high treatment-completion rate mean the program worked?
Not by itself. Completion tells you how many people finished. It does not show if they stayed well afterward. Ask for substance-use and other outcomes, too. Also ask if results include everyone who started, or only those who stayed.
Does relapse mean treatment failed?
No. Going back to use does not mean you cannot benefit from more care. Recovery often has setbacks, and each one can guide changes. Talk with your care team without judgment. Ask what support or treatment changes might help now.
Can a study's success rate predict what will happen to me?
A study shows how a group did with a specific approach. It cannot promise your result, though your situation matters most. Ask if the program uses the same method for people like you. Also ask how it tracks its own results over time.